Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O6-methylguanine-DNA methyltransferase

Acquisition of temozolomide (TMZ) resistance is a major factor leading to the failure of glioblastoma (GBM) treatment. The exact mechanism by which GBM evades TMZ toxicity is not always related to the expression of the DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT), and so remains u...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Kwang-Yu Chang, Tsung-I. Hsu, Che-Chia Hsu, Shan-Yin Tsai, Jr-Jiun Liu, Shao-Wen Chou, Ming-Sheng Liu, Jing-Ping Liou, Chiung-Yuan Ko, Kai-Yun Chen, Jan-Jong Hung, Wen-Chang Chang, Cheng-Keng Chuang, Tzu-Jen Kao, Jian-Ying Chuang
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2017-10-01
Serie:	Redox Biology
Soggetti:	Specificity protein 1 Superoxide dismutase 2 Reactive oxygen species Temozolomide O6-methylguanine-DNA methyltransferase
Accesso online:	http://www.sciencedirect.com/science/article/pii/S2213231717305888
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!